Search Results

(+)-Igmesine hydrochloride Please inquire  | 98%

BOC Sciences

Igmesine is a selective σ1 receptor ligand (KD = 19.1 nM), with nearly no activity at σ2 receptors (IC50 > 1000 nM). It was developed by Pfizer. Igmesine inhibits the NMDA-induced increase in cGMP in a concentration-dependent manner and IC50 value is approximately 100 nM. Igmesine can weekly inhibit brain 5-HT uptake in vitro. It […]

More Information Supplier Page

(+)-Intermedine 5 mg  | Purity Not Available

TargetMol

(+)-Intermedine, a pyrrolizidine alkaloid (PA), shows remarkable cytotoxic activity against neural progenitor cells (NPCs).

More Information Supplier Page